Chapter 17
Liver Resection of Colorectal Liver Metastases
Daria Zorzi MD,
Yun Shin Chun MD,
Jean-Nicolas Vauthey MD, FACS,
Daria Zorzi MD
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer, Center, Houston, TX, USA
Search for more papers by this authorYun Shin Chun MD
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer, Center, Houston, TX, USA
Search for more papers by this authorJean-Nicolas Vauthey MD, FACS
Professor of Surgery
Liver Service, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer, Center, Houston, TX, USA
Search for more papers by this authorDaria Zorzi MD,
Yun Shin Chun MD,
Jean-Nicolas Vauthey MD, FACS,
Daria Zorzi MD
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer, Center, Houston, TX, USA
Search for more papers by this authorYun Shin Chun MD
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer, Center, Houston, TX, USA
Search for more papers by this authorJean-Nicolas Vauthey MD, FACS
Professor of Surgery
Liver Service, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer, Center, Houston, TX, USA
Search for more papers by this authorBook Editor(s):Pierre-Alain Clavien MD, Phd, FACS, FRCS,
Stefan Breitenstein MD,
Pierre-Alain Clavien MD, Phd, FACS, FRCS
Professor Chairman
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorStefan Breitenstein MD
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorFirst published: 09 December 2009
Summary
This chapter contains sections titled:
-
Preoperative considerations and work-up
-
Selection of surgical candidates
-
Surgical techniques
-
Methods to improve resectability
-
Conclusion
-
Self-assessment questions
-
References
-
Self-assessment answers
References
- Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 5: 715–24.
- Vauthey JN, Zorzi D, Pawlik TM. Making unresectable hepatic colorectal metastases resectable–does it work? Semin Oncol 2005; 6 (Suppl 9): S118–22.
- Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 2005; 4: 338–51.
- Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 4: 644–57.
- Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis–meta-analysis. Radiology 2005; 1: 123–31.
- Akhurst T, Kates TJ, Mazumdar M, et al. Recent chemotherapy reduces the sensitivity of [18F]fl uorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005; 34: 8713–16.
- Khan AZ, Karanjia ND. The impact of staging laparoscopy prior to hepatic resection for colorectal metastases. Eur J Surg Oncol 2007; 8: 1010–13.
- Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 3: 309–18.
- Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 6: 759–66.
- Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 4: 487–99.
- Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Brisbane 2000 Terminology? (more than one answer is possible) Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007–16.
- Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007; 1: 324–38.
- Jaeck D, Nakano H, Bachellier P, et al. Signifi cance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 2002; 5: 430–8.
- Laurent C, Sa Cunha A, Couderc P, et al. Infl uence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 2003; 9: 1131–6.
- Jaeck D. The signifi cance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 2003; 9: 1007–11.
- Yang YY, Fleshman JW, Strasberg SM. Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases. J Gastrointest Surg 2007; 7: 929–44.
- Elias D, Liberale G, Vernerey D, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005; 11: 900–9.
- Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 6: 675–80.
- Ribero D, Abdalla EK, Madoff DC, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 11: 1386–94.
-
Wanebo HJ, Chu QD, Vezeridis MP, et al. Patient selection for hepatic resection of colorectal metastases. Arch Surg 1996; 3: 322–9.
10.1001/archsurg.1996.01430150100019 Google Scholar
- Couinaud C. Lobes et segments hépatiques: notes sur I'architecture anatomiques et chirurgicale du foie. La Presse Medicale 1954: 709–12.
-
Strasberg SM, for the International Hepato-Pancreato-Biliary Association Terminology Committee Survey. The Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB (Oxf) 2000; 3: 333–9.
10.1016/S1365-182X(17)30755-4 Google Scholar
- Kokudo N, Tada K, Seki M, et al. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 2001; 2: 153–9.
- Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 9: 1219–22.
- Zorzi D, Mullen JT, Abdalla EK, et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 2006; 1: 86–94.
- Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000; 6: 777–85.
- Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 6: 1037–49.
- Chun YS, Vauthey JN, Ribero D, et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 2007; 11: 1498–504.
- Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conventional approach right hepatic resection for large hepato- cellular carcinoma: a prospective randomized controlled study. Ann Surg 2006; 2: 194–203.
- Belghiti J, Guevara OA, Noun R, et al. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 2001; 1: 109–11.
- Kooby DA, Stockman J, Ben-Porat L, et al. Infl uence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 6: 860–9.
- Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992; 4: 493–504.
- Ishizaki Y, Yoshimoto J, Miwa K, et al. Safety of prolonged intermittent pringle maneuver during hepatic resection. Arch Surg 2006; 7: 649–53.
- Aloia TA, Zorzi D, Abdalla EK, et al. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection Ann Surg 2005; 2: 172–7.
- Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998; 4: 566–71.
- Steele G Jr, Bleday R, Mayer RJ, et al. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 1991; 7: 1105–12.
- Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fl uorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 6: 663–9.
- Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fl uorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 23: 2335–42.
- Wicherts DA, de Haas RJ, Adam R. Bringing unresectable liver disease to resection with curative intent. Eur J Surg Oncol 2007; 33 (Suppl): S42–51.
- Kopetz S, Vauthey JN. Perioperative chemotherapy for resectable hepatic metastases Lancet 2008; 371: 963–65.
- Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007–16.
- Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006; 24: 3939–45.
- Peppercorn PD, Reznek RH, Wilson P, et al. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fl uorouracil-based therapy for advanced colorectal cancer. Br J Cancer 1998; 11: 2008–11.
- Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 3: 460–6.
- Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fl uorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 31: 4983–90.
- Nordlinger B, Sorbye M, Debois M, et al. Feasibility and risks of pre-operative chemotherapy (CT) with FOLFOX 4 and surgery for resectable colorectal cancer liver metastases (LM). Interim results of the EORTC Intergroup randomized phase III study 40983. Proceedings of the American Society of Clinical Oncology, 2005: 253s.
- Karoui M, Penna C, Amin-Hashem M, et al. Infl uence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 1: 1–7.
- Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 13: 2065–72.
- D'Angelica M, Kornprat P, Gonen M, et al. (2007) Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol 2007; 2: 759–65.
- Ribero D, Wang H, Donadon M, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007; 12: 2761–7.
- Adam R, Aloia T, Levi F, et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 2007; 29: 4593–602.
-
Zacharia TT. Assessment of future remnant liver regeneration after portal vein embolization using three-dimensional CT and MR volumetric analyses. Australas Radiol 2006; 6: 543–8.
10.1111/j.1440-1673.2006.01625.x Google Scholar
- Johnson TN, Tucker GT, Tanner MS, et al. Changes in liver volume from birth to adulthood: A meta-analysis. Liver Transpl 2005; 12: 1481–93.
- Hirai I, Kimura W, Fuse A, et al. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003; 5: 495–506.
- Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 2: 208–17.
- Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 2007; 33 (Suppl 2): 52–8.
- Kusaka K, Imamura H, Tomiya T, et al. Expression of transforming growth factor-alpha and-beta in hepatic lobes after hemihepatic portal vein embolization. Dig Dis Sci 2006; 8: 1404–12.
- Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 10: 1271–80.
